Press Release November 21, 2017

BYLINE: Criticism Of FDA Citizen Petitions Is Often Misguided (Law360)

Life Sciences partner Scott Lassman discusses why it’s important for critics of the citizen petition process to have a clear understanding of relevant FDA regulations, requirements and data before calling for regulatory or legislative changes.

Read the full article.